2018 tables: Institutions - life sciences - corporate

Table criteria

The 2018 tables are based on Nature Index data from 1 January 2017 to 31 December 2017.

2017 Institution FC 2016 FC 2017
1 Merck & Co., Inc., United States of America (USA) 7.06 12.39
2 Amgen Inc., United States of America (USA) 13.49 10.66
3 Pfizer Inc., United States of America (USA) 14.92 10.54
4 Johnson & Johnson, United States of America (USA) 5.15 5.54
5 AbbVie Inc., United States of America (USA) 0.2 5.01
6 Regeneron Pharmaceuticals, Inc., United States of America (USA) 4.57 4.95
7 Alphabet Inc., United States of America (USA) 3.87 4.48
8 Ionis Pharmaceuticals, Inc., United States of America (USA) 3.58 4.44
9 Biogen Inc., United States of America (USA) 2.74 4.04
10 IBM Corporation, United States of America (USA) 0.43 3.98
11 New England Biolabs, Inc. (NEB), United States of America (USA) 1.57 3.63
12 Eli Lilly and Company, United States of America (USA) 7.98 3.37
13 Bristol-Myers Squibb (BMS), United States of America (USA) 2.54 3.24
14 Leidos Holdings, Inc., United States of America (USA) 4.98 3.21
15 Illumina, Inc., United States of America (USA) 2.71 3.17
16 Human Longevity, Inc., United States of America (USA) 0.99 2.74
17 H3 Biomedicine Inc., United States of America (USA) 0.5 2.58
18 NGM Biopharmaceuticals, Inc., United States of America (USA) 0.64 2.54
19 Synthetic Genomics, Inc. (SGI), United States of America (USA) 1.4 2.3
20 Foundation Medicine, Inc., United States of America (USA) 1.04 2.15
21 10x Genomics, United States of America (USA) 1.12 2.01
22 DowDuPont Inc., United States of America (USA) 4.64 1.87
23 Thermo Fisher Scientific Inc., United States of America (USA) 1.62 1.75
24 Adaptive Biotechnologies LLC, United States of America (USA) 0.32 1.75
25 SomaLogic, Inc., United States of America (USA) 0.05 1.68
26 Gilead Sciences, Inc., United States of America (USA) 1.94 1.64
27 23andMe, Inc., United States of America (USA) 1.82 1.49
28 Oncomed Pharmaceutical, Inc., United States of America (USA) 1.17 1.4
29 Noble Research Institute, LLC, United States of America (USA) 2.24 1.39
30 Microsoft Corporation, United States of America (USA) 1.28 1.38
31 HRL Laboratories LLC, United States of America (USA) 1.13
32 Adimab LLC, United States of America (USA) 0.2 1.09
33 Immunomedics, Inc., United States of America (USA) 1
33 BioMarin Pharmaceutical, United States of America (USA) 1
33 Editas Medicine, Inc., United States of America (USA) 0.2 1
33 MyoKardia, United States of America (USA) 0.59 1
34 Wave Life Sciences Ltd., United States of America (USA) 0.95
35 SRI International, United States of America (USA) 0.27 0.9
36 Pacific Biosciences of California, Inc., United States of America (USA) 1.65 0.88
37 Ancestry.com, Inc., United States of America (USA) 0.04 0.84
38 Merrimack Pharmaceuticals, Inc., United States of America (USA) 1.21 0.81
39 Caribou Biosciences, Inc., United States of America (USA) 0.71 0.81
40 Blueprint Medicines, United States of America (USA) 0.81
41 Celgene Corporation, United States of America (USA) 1.03 0.8
42 Translate Bio, Inc., United States of America (USA) 0.78
43 Everon Biosciences, Inc., United States of America (USA) 0.75
44 Sanaria Inc., United States of America (USA) 0.23 0.74
45 Epic Sciences Inc., United States of America (USA) 0.67
46 Ironwood Pharmaceuticals, Inc., United States of America (USA) 0.64
47 Cell Signaling Technology, Inc., United States of America (USA) 0.08 0.63
48 Inter-American Development Bank (IDB), United States of America (USA) 0.63
49 Arcturus Therapeutics, Inc., United States of America (USA) 0.04 0.63
50 Metabolon Inc., United States of America (USA) 0.36 0.6

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. It is important for users to understand that the data behind the tables are based on a relatively small proportion of total research papers, that they cover the natural sciences only and that outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output). We encourage users to combine the free-to-access Nature Index data with information from other sources.

The tables were last updated on 7 June 2018 with the most recent institution and article corrections.

*The change in adjusted FC accounts for the small annual variation in the total number of articles in Nature Index journals. FC values have been adjusted to 2017 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.

Looking for more data? Create your own profile to see time trend graphs of institutions and countries. Registrants can also download data from tables and create website widgets.